Blood signature found to predict lung cancer risk years before diagnosis
Researchers at the Walter and Eliza Hall Institute have identified a blood signature capable of predicting lung cancer risk years before clinical diagnosis. This discovery could potentially expand screening eligibility beyond current tobacco-focused criteria to include non-smokers exposed to environmental pollutants.
Why it matters
Current lung cancer screening is limited to smokers, leaving a significant portion of the population vulnerable; this breakthrough could enable life-saving early intervention for non-smokers.
Around a quarter of the estimated 15,000 Australians diagnosed with lung cancer each year have no smoking history.
The report is a straightforward summary of medical research findings from a reputable scientific institution without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in